Efficacy and Safety of Oral Antidiabetic Drugs in Comparison to Insulin in Treating Gestational Diabetes Mellitus: A Meta-Analysis
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess the efficacy and safety of oral antidiabetic drugs (OADs) in gestational diabetes mellitus (GDM) in comparison to insulin. METHODS: A meta-analysis of randomized controlled trials was conducted. The efficacy and safety of OADs in comparison to insulin in GDM patients were explored. Studies were identified by conducting a literature search using the electronic databases of Medline, CENTRAL, CINAHL, LILACS, Scopus and Web of Science in addition to conducting hand search of relevant journals from inception until October 2013. RESULTS: Thirteen studies involving 2,151 patients met the inclusion criteria. These studies were randomized controlled trials of metformin and glyburide in comparison to insulin therapy. Our results indicated a significant increase in the risk for preterm births (RR, 1.51; 95% CI, 1.04-2.19, p = 0.03) with metformin compared to insulin. However, a significant decrease in the risk for gestational hypertension (RR, 0.54; 95% CI, 0.31-0.91, p = 0.02) was found. Postprandial glucose levels also decreased significantly in patients receiving metformin (MD, -2.47 mg/dL; 95% CI, -4.00, -0.94, p = 0.002). There was no significant difference between the two groups for the remaining outcomes. There were significant increases in the risks of macrosomia (RR, 2.34; 95% CI, 1.18-4.63, p = 0.03) and neonatal hypoglycemia (RR, 2.06; 95% CI, 1.27-3.34, p = 0.005) in the glyburide group compared to insulin whereas results for the other analyzed outcomes remained non-significant. CONCLUSION: The available evidence suggests favorable effects of metformin in treating GDM patients. Metformin seems to be an efficacious alternative to insulin and a better choice than glyburide especially those with mild form of disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The HAPO study confirmed findings in Pima Indians1409 that, even among offspring of women without GDM as it is currently defined, there is a linear association between maternal glucose concentration during pregnancy and newborn weight, rates of large-for-gestational-age, and cesarean delivery.64,1418–1421”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1421]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Both low and high birth weight are associated with higher rates of DM.1421”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1421]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · cited 1×
“We conducted this meta-analysis according to Cochrane Handbook for Systematic Reviews of Interventions [17], and data are presented according to the recommendations of PRISMA statement [18].”
MethodBias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722 · cited 1×
“We assessed reporting bias by using Egger’s test [19] in case five or more studies were included for an outcome.”
MethodPreferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1. The Cochrane Collaboration
Higgins, J. P. T., Green, S. R., & Higgins, J. P. T. (2008) · Cited by 7,226
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Bellamy, L., Casas, J.-P., Hingorani, A. D., & Williams, D. J. (2007) · BMJ · doi:10.1136/bmj.39335.385301.be · Cited by 2,552
Gestational Diabetes and the Incidence of Type 2 Diabetes
Kim, C., Newton, K. M., & Knopp, R. H. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1862 · Cited by 2,276 · cited 1×
“Normally, GDM ends at the termination of pregnancy; however, such patients are at a higher risk for development of type 2 diabetes mellitus later in their life [2].”
BackgroundDiagnosis and classification of diabetes mellitus
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s067 · Cited by 2,245
Research works printed but not linked: 1
- 14. The American College of Obstetricians and Gynecologists (2013) Gestational diabetes mellitus: Clinical management guidelines for obstetricians-gynecolo- gists. Obstet Gynecol 122: 406-416.
Cited by
ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002501 · Cited by 1,820
Practice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
A Clinical Update on Gestational Diabetes Mellitus
Sweeting, A., Wong, J., Murphy, H. R., & Ross, G. P. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac003 · Cited by 928
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
ACOG Practice Bulletin No. 201: Pregestational Diabetes Mellitus
(2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002960 · Cited by 470
Feig, D. S., Berger, H., Donovan, L., Godbout, A., Kader, T., Keely, E., & Sanghera, R. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.038 · Cited by 344
Practice Bulletin No. 180: gestational diabetes mellitus.
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002159 · Cited by 324
Guo, L., Ma, J., Tang, J., Hu, D., Zhang, W., & Zhao, X. Q. (2019) · Journal of Diabetes Research · doi:10.1155/2019/9804708 · Cited by 157
Nachum, Z., Zafran, N., Salim, R., Hissin, N., Hasanein, J., Gam Ze Letova, Y., Suleiman, A., & Yefet, E. (2017) · Diabetes Care · doi:10.2337/dc16-2307 · Cited by 118
“distress, neonatal hypoglycemia, birth injury, increased birth weight, large-forgestational-age neonate, and macrosomia (3,13,14,19).”
Background2019 Guidelines on the management of diabetic patients. A position of Diabetes Poland
Araszkiewicz, A., Bandurska-Stankiewicz, E., Budzyński, A., Cypryk, K., Czech, A., Czupryniak, L., Drzewoski, J., Dzida, G., Dziedzic, T., Franek, E., et al. (2019) · Clinical Diabetology · doi:10.5603/dk.2019.0001 · Cited by 123
Sénat, M.-V., Affres, H., Letourneau, A., Coustols-Valat, M., Cazaubiel, M., Legardeur, H., Jacquier, J. F., Bourcigaux, N., Simon, E., Rod, A., et al. (2018) · JAMA · doi:10.1001/jama.2018.4072 · Cited by 114
Tsakiridis, I., Giouleka, S., Mamopoulos, A., Kourtis, A., Athanasiadis, A., Filopoulou, D., & Dagklis, T. (2021) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000899 · Cited by 94
Comparison of glyburide and insulin in the management of gestational diabetes: a meta-analysis
Song, R., Chen, L., Chen, Y., Si, X., Liu, Y., Liu, Y., Irwin, D. M., & Feng, W. (2017) · PLOS ONE · doi:10.1371/journal.pone.0182488 · Cited by 73
Metformin in the management of diabetes during pregnancy and lactation
Priya, G., & Kalra, S. (2018) · Drugs in Context · doi:10.7573/dic.212523 · Cited by 99
“Poolsup, 2014 [43] 13 RCTs, 2151 patients; oral antidiabetics versus insulin Significantly lower PPG with metformin.”
BackgroundLandi, S. N., Radke, S., Engel, S. M., Boggess, K., Stürmer, T., Howe, A. S., & Funk, M. J. (2019) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2018.4214 · Cited by 64
2023 Guidelines on the management of patients with diabetes - a position of Diabetes Poland
Araszkiewicz, A., Bandurska-Stankiewicz, E. M., Borys, S., Budzynski, A. Z., Cyganek, K., Cypryk, K., Czech, A., Czupryniak, L., Drzewoski, J., Dzida, G. J., et al. (2023) · Current Topics in Diabetes · doi:10.5114/ctd/160061 · Cited by 85
Clinical Management of Women with Monogenic Diabetes During Pregnancy
Dickens, L. T., & Naylor, R. N. (2018) · Current Diabetes Reports · doi:10.1007/s11892-018-0982-8 · Cited by 58
Gestational Diabetes Mellitus:current knowledge and unmet needs
Koning, S. H., Hoogenberg, K., Lutgers, H. L., van den Berg, P. P., & Wolffenbuttel, B. H. R. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12422 · Cited by 61
“included an additional RCT(86); they also did not address exactly the same outcomes: Poolsup et al.(77) had no information on maternal weight gain and Balsells et al.”
BackgroundResultInfluential2022 Guidelines on the management of patients with diabetes. A position of Diabetes Poland
Araszkiewicz, A., Bandurska-Stankiewicz, E. M., Borys, S., Budzynski, A. Z., Cyganek, K., Cypryk, K., Czech, A., Czupryniak, L., Drzewoski, J., Dzida, G. J., et al. (2022) · Current Topics in Diabetes · doi:10.5114/ctd/146259 · Cited by 69
Neonatal outcomes according to different therapies for gestational diabetes mellitus
Silva, A. L. D., Amaral, A. R. D., Oliveira, D. S. D., Martins, L., Silva, M. R. E., & Silva, J. C. (2017) · Jornal de Pediatria · doi:10.1016/j.jped.2016.04.004 · Cited by 40
Shepherd, M. H., Brook, A., Chakera, A. J., & Hattersley, A. T. (2017) · Diabetic Medicine · doi:10.1111/dme.13388 · Cited by 43
“However evidence from its use in gestational diabetes mellitus (GDM) now clearly demonstrates that glibenclamide crosses the placenta [6,7] and stimulates fetal insulin secretion, resulting in increased fetal growth and increased rates of neonatal hypoglycaemia [8-10].”
Amin, M., Suksomboon, N., Poolsup, N., & Malik, O. (2015) · Clinical Drug Investigation · doi:10.1007/s40261-015-0289-3 · Cited by 40
“with insulin, which corresponds with the findings of this review [38].”
ResultSelf-citationManagement of pregestational diabetes mellitus: a comparison of guidelines
Tsakiridis, I. G., Mamopoulos, A. M., Athanasiadis, A. P., Kourtis, A., & Dagklis, T. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1719481 · Cited by 36
Yu, D., Xu, G., Teng, X., Xu, J., Tang, L., Feng, C., Rao, J., Jin, M., & Wang, L. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00865-9 · Cited by 56
Pharmacological treatment of gestational diabetes mellitus: point/counterpoint
Langer, O. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.01.024 · Cited by 27
Affres, H., Sénat, M., Letourneau, A., Deruelle, P., Coustols-Valat, M., Bouchghoul, H., & Bouyer, J. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2020.11.002 · Cited by 21
Musa, O. A. H., Syed, A., Mohamed, A. M., Chivese, T., Clark, J. M., Furuya‐Kanamori, L., Xu, C., Toft, E. S., Bashir, M., Abou‐Samra, A., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105546 · Cited by 27
Prevention of Hypertensive Disorders of Pregnancy—Is There a Place for Metformin?
Poniedziałek‐Czajkowska, E., Mierzyński, R., Dłuski, D. F., & Leszczyńska‐Gorzelak, B. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132805 · Cited by 22
Pharmacologic Treatment of Diabetes in Pregnancy
Bishop, K. C., Harris, B. S., Boyd, B. K., Reiff, E. S., Brown, L., & Kuller, J. A. (2019) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0000000000000671 · Cited by 21
“There were no differences in risk of PTB, neonatal mortality, congenital abnormalities, or small-forgestational-age births.(47)”
BackgroundResultComparative effectiveness of metformin versus insulin for gestational diabetes in New Zealand
Landi, S. N., Radke, S., Boggess, K., Engel, S. M., Stürmer, T., Howe, A. S., & Funk, M. J. (2019) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.4907 · Cited by 21
“Our data as well as those of two recent meta‐analyses of randomized trials show that metformin may have positive effects on GDM‐treated women and infants.(7,10) Furthermore, our study provides much‐needed information on real‐world comparative effectiveness of metformin compared with insulin.”
BackgroundManagement and Outcomes of Maturity-Onset Diabetes of the Young in Pregnancy
Monsonego, S., Clark, H. D., Karovitch, A. J., O’Meara, P., Shaw, T., & Malcolm, J. (2019) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2019.07.004 · Cited by 18
Vanlalhruaii, Dasgupta, R., Ramachandran, R., Mathews, J. E., Regi, A., Thomas, N., Gupta, V., Visalakshi, P., Asha, H. S., Paul, T. V., et al. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.01.002 · Cited by 17
Standards of Care in Diabetes. The position of Diabetes Poland – 2024
Araszkiewicz, A., Bandurska-Stankiewicz, E. M., Borys, S., Broncel, M., Budzynski, A. Z., Cyganek, K., Cypryk, K., CYRANKA, K. M., Czupryniak, L., Dzida, G. J., et al. (2024) · Current Topics in Diabetes · doi:10.5114/ctd/183052 · Cited by 33
Bowker, S. L., Savu, A., Yeung, R. O., Johnson, J. A., Ryan, E. A., & Kaul, P. (2017) · Diabetic Medicine · doi:10.1111/dme.13394 · Cited by 17
Novel therapies for diabetes mellitus in pregnancy
Feghali, M. N., & Scifres, C. (2018) · BMJ · doi:10.1136/bmj.k2034 · Cited by 17
Longer-term outcomes in offspring of GDM mothers treated with metformin versus insulin
Zhen, X. M., Li, X., & Chen, C. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.07.002 · Cited by 17
Yarandi, R. B., Amiri, M., Tehrani, F. R., & Behboudi‐Gandevani, S. (2021) · Journal of Diabetes Investigation · doi:10.1111/jdi.13603 · Cited by 17
Insulin detemir versus glyburide in women with gestational diabetes mellitus
Koren, R., Ashwal, E., Hod, M., & Toledano, Y. (2016) · Gynecological Endocrinology · doi:10.1080/09513590.2016.1209479 · Cited by 14
“the risk of macrosomia and neonatal hypoglycemia in comparison with insulin [17].”
ResultResearch progress of metformin in gestational diabetes mellitus: a narrative review
Ouyang, H., Al-Mureish, A., & Wu, N. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-21-192 · Cited by 19
“Therefore, to further understand the therapeutic effect of metformin on GDM, we summarized some studies on the control of blood glucose by metformin in pregnant women with GDM to further explore the effect of metformin on blood glucose in GDM in Table 1 (35-51).”
BackgroundInfluentialDrugs to Control Diabetes During Pregnancy
Feghali, M. N., Umans, J. G., & Catalano, P. M. (2019) · Clinics in Perinatology · doi:10.1016/j.clp.2019.02.005 · Cited by 16
Bouchghoul, H., Alvarez, J., Verstuyft, C., Bouyer, J., & Sénat, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0232002 · Cited by 17
Bodier, L., Lous, M. L., Isly, H., Derrien, C., & Vaduva, P. (2025) · Diabetes & Metabolism · doi:10.1016/j.diabet.2025.101622 · Cited by 21
Ouyang, H., & Wu, N. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01142-7 · Cited by 16
Management of monogenic diabetes in pregnancy: A narrative review
Jeeyavudeen, M. S., Murray, S. R., & Strachan, M. W. J. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i1.15 · Cited by 10
Zhen, X. M., Li, X., & Chen, C. (2018) · Obesity Medicine · doi:10.1016/j.obmed.2018.08.001 · Cited by 12
Neonatal outcomes according to different therapies for gestational diabetes mellitus
da Silva, A. L., do Amaral, A. R., Oliveira, D. S., Martins, L., Silva, M. R. E., & Silva, J. C. (2017) · Jornal de Pediatria (Versão em Português) · doi:10.1016/j.jpedp.2016.07.004 · Cited by 11
Recent advances in the antepartum management of diabetes
Mitric, C., Desilets, J., & Brown, R. N. (2019) · F1000Research · doi:10.12688/f1000research.15795.1 · Cited by 11
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · BMC Medicine · doi:10.1186/s12916-023-02758-1 · Cited by 15
Gestational Diabetes Mellitus: New Diagnostic Criteria
Bortolon, L. N. M., Triz, L. D. P. L., Faustino, B. D. S., de Sá, L. B. P. C., Rocha, D. R. T. W., & Arbex, A. K. (2016) · Open Journal of Endocrine and Metabolic Diseases · doi:10.4236/ojemd.2016.61003 · Cited by 13
“Although metformin has possible effect on crossing the placenta lye, it is not responsible for teratogenic effects during the first pregnancy quarter [17]-[19].”
BackgroundMaturity-onset Diabetes of the Young (MODY) in Pregnancy: A Review
Majewska, A., Stanirowski, P. J., Wielgoś, M., & Bomba-Opon, D. A. (2022) · Current Diabetes Reviews · doi:10.2174/1573399818666220128124043 · Cited by 8
Malfertheiner, S. F., Gutknecht, D., & Bals‐Pratsch, M. (2017) · Geburtshilfe und Frauenheilkunde · doi:10.1055/s-0043-122279 · Cited by 8
Masood, S. N., Baqai, S. M., Naheed, F., Masood, Y., Sikandar, R., Chaudhri, R., Yasmin, H., & Korejo, R. (2021) · Journal of Diabetology · doi:10.4103/jod.jod_88_20 · Cited by 12
Metformin in Pregnancy for Women with Type 2 Diabetes: a Review
Benham, J. L., Donovan, L., & Yamamoto, J. M. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01409-0 · Cited by 8
Oral hypoglycemic agents: do the ends justify the means?
Langer, O. (2015) · Maternal Health Neonatology and Perinatology · doi:10.1186/s40748-015-0021-6 · Cited by 5
“Dhulkotia [45] Poolsup [59] Balsells [35] Zeng [49] Jiang [34] Gui [60]”
BackgroundInfluentialControversies in Gestational Diabetes
Zera, C., & Seely, E. W. (2021) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2021.17.2.102 · Cited by 10
“In addition, metformin use has been associated with less maternal weight gain and lower risk for preeclampsia than insulin.(64,66) As seen in the MiG trial, there was a higher risk for spontaneous preterm birth with metformin than insulin.”
BackgroundResultInfluentialShannon, M. H., Wintfeld, N., Liang, M., & Jovanovič, L. (2016) · Current Medical Research and Opinion · doi:10.1185/03007995.2016.1164128 · Cited by 5
Diabetes in Pregnancy: Preconception to Postpartum
Healy, A. M. (2022) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2021.11.009 · Cited by 6
Alahdal, M., Jing, L., Shiping, L., Xing, Y., Gao, H., Jialei, Z., Hassan, W., Jin, L., & Rongyue, C. (2018) · Autoimmunity · doi:10.1080/08916934.2018.1519704 · Cited by 3
“These evidences prove an antidiabetic efficiency [33].”
Antidiabétiques oraux et grossesse
Sénat, M. (2017) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(17)30120-7 · Cited by 7
Daud, N. A. A., Mohiuddin, S. G., Ong, Y. P., Yusof, F. A. M., Yusoff, F., Harun, S. N., & Ghadzi, S. M. S. (2021) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_542_20 · Cited by 3
“[6,14,16] Regarding the practice in managing GDM among the respondents, only 27% of the respondents had prescribed or dispensed metformin for GDM previously, especially when the patients were already treated for prepregnancy diabetes.”
Rol de la metformina en el tratamiento de la diabetes mellitus gestacional: situación actual
Miranda, P. J. P., Palacios, L. P. T., Cueva, J. L. C., Avilés, G. A. H., Maldonado, E. I. B., Moya, J. I. E., Moya, J. R. E., Acosta, J. M. S., & Lozada, E. M. V. (2019) · Archivos Venezolanos de Farmacología y Terapéutica · Cited by 10
Tratamiento actual de la diabetes gestacional
Salat, D., & Aguilera, C. (2015) · Medicina Clínica · doi:10.1016/j.medcli.2015.04.014 · Cited by 6
Medications for Pregnant Women With Obesity: Special Considerations
Maggio, L. (2020) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000584 · Cited by 2
Metformina y gliburida en el tratamiento de la diabetes gestacional
de Santander, M. I. X. N. D. M. U. I., Hernández, A. A., Castillo, D. R., & de Santander, U. I. (2015) · Revista Médicas UIS · doi:10.18273/revmed.v28n3-2015008 · Cited by 5
The High-Risk Obstetric Patient: Pregnancy-Induced Conditions
Curbelo, J. (2021) · Oxford University Press eBooks · doi:10.1093/med/9780190099824.003.0007 · Cited by 1
Rommy, Karinaningrum, A. D., Luthfiananda, B., Aniq, L., Evelina, L. S., & Fauzi, R. (2022) · Indonesian Journal of Pharmacology and Therapy · doi:10.22146/ijpther.3244 · Cited by 1
Yanchuan, L. I., Yanfeng, L. I. U., Jingxuan, P. E. N. G., Shengjun, W. U., Xue, L. I., Haili, W. A. N. G., & Qiuhui, Q. U. (2021) · Minerva Medica · doi:10.23736/s0026-4806.21.07877-0 · Cited by 1
Current treatment for gestational diabetes
Salat, D., & Aguilera, C. (2015) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2016.02.025 · Cited by 1
Metformin: A Drug of Choice for Gestational Diabetes Mellitus in Near Future- Hope or Despair?
Alam, A. T., & Ahmed, S. S. (2015) · Chattagram Maa-O-Shishu Hospital Medical College Journal · doi:10.3329/cmoshmcj.v14i2.25722
Hernández, A. A., & Castillo, D. R. (2015)
Landi, S. N. (2018) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/da5p-j697
Gestationsdiabetes und polyzystisches Ovarialsyndrom
Kollmann, M. (2021) · Journal für Klinische Endokrinologie und Stoffwechsel · doi:10.1007/s41969-021-00143-y
Brown, Z. A., & Chang, J. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-40139-5.00010-3 · Cited by 2
Precision Genetics for Monogenic Diabetes
Luk, A. O. Y., & Lim, L. (2022) · Springer eBooks · doi:10.1007/978-3-030-98927-9_6
Metformin in the management of gestational diabetes
Rotar, I. C., Stănică, B., Petca, A. T., & Mureșan, D. (2022) · Obstetrica şi Ginecologia · doi:10.26416/obsgin.70.2.2022.6682
伍, 婷. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.133581
Rehman, A., Fatima, S., Ahmed, Z., Rehman, A., & Rehman, H. (2023) · doi:10.53555/jptcp.v30i18.3139
Resnick, B., Shepherd, M. H., & Hattersley, A. T. (2024) · Wiley eBooks · doi:10.1002/9781119697473.ch20
Neonatal and Childhood Consequences of Maternal Obesity and Diabetes
Hulst, A. V., Savard, C., Harnois‐Leblanc, S., Gingras, V., & Henderson, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-23940-3.00016-8
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800535
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800514
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800502
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655484
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655499
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800520
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800505
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800532
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800517
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655508
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655511
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800529
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800523
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800526
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655481
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655505
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800538
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800508
Yu, D.-Q., Xu, G.-X., Teng, X.-Y., Xu, J.-W., Tang, L.-F., Feng, C., Rao, J.-P., Jin, M., & Wang, L.-Q. (2021) · Figshare · doi:10.6084/m9.figshare.16800499
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655496
Semertzidou, A., Grout-Smith, H., Kalliala, I. E. J., Garg, A., Terzidou, V., Marchesi, J. R., MacIntyre, D. A., Bennett, P. R., Tsilidis, K. K., & Kyrgiou, M. (2023) · Figshare · doi:10.6084/m9.figshare.22655493
Metadata
- Authors
- Poolsup, N., Suksomboon, N., & Amin, M.
- Affiliations
- Silpakorn University (TH)
- Mahidol University (TH)
- Corresponding author
- Suksomboon, Naeti
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-10-10
- Volume
- 9
- Issue
- 10
- Pages
- e109985
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4193853
- OpenAlex
- W2041276822
- Cited by
- 107
- References
- 49
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 3 · 2023: 15 · 2022: 8 · 2021: 30 · 2020: 4 · 2019: 9 · 2018: 14 · 2017: 9 · 2016: 5 · 2015: 7
- FWCI
- 1.12
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Greater South Information System
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- gestational diabetes mellitus, oral antidiabetic drugs, metformin, glibenclamide, insulin therapy, preterm birth, gestational hypertension, macrosomia, neonatal hypoglycemia, postprandial blood glucose, drug safety
- MeSH terms
- Female, Glyburide, Humans, Hypoglycemic Agents, Insulin, Metformin, Pregnancy, Diabetes, Gestational, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.